Skip to content
Screener

OraSure Technologies OSUR Risk Assessment Testing — Net revenues

Other product segments

HIV
$14.17M-1.6%
Sample Management Solutions
$9.88M+0.2%
HCV
$3.39M-17.8%
Other Product And Services Revenues
$2.29M+130%
Other
$915K
COVID-19
$1K-96.4%

Similar metrics at other companies

ROP
ROPProduct Revenue — Net revenues
$462.7M+7.7%
Travel + Leisure logo
TNLDeferred subscription revenue — Net revenues
$42M-2.3%
ROP
ROPTotal Software Revenue — Net revenues
$1.63B+12.4%
Travel + Leisure logo
TNLDeferred exchange-related revenue — Net revenues
$9M0.0%
Gen Digital Inc. logo
GENSubscription and service revenue — Net revenues
$1.33B+6.2%
Travel + Leisure logo
TNLAncillary revenues — Net revenues
$0-100%

Other financials

Income statement

See full
Revenue$30.6M-1.9%
Gross profit$13.3M+1.2%
Operating income$5.4M+130%
Net income$6.2M+132%
EPS (diluted)$0.09+135%

Balance sheet

See full
Cash & equivalents$160.6M-31.5%
Total debt$12.1M-14.4%
Total equity$317.8M-16.5%
Total assets$360.6M-19.0%

Cash flow

See full
Operating cash flow-$9.9M+3.0%
CapEx$2.4M+25.4%
Free cash flow-$12.3M-1.6%

Valuation

See full
Market cap$275.87M+35.2%
Enterprise value$127.39M-877%
P/S2.5×+1.0×

Profitability

See full
Gross margin42.6%+2.1pp
Operating margin-48.1%+14.2pp
Net margin-43.7%+10.0pp
FCF margin-42.8%-85.7pp

Returns & leverage

See full
Return on equity-14.1%+1.8pp
Debt / equity0.0×
Current ratio8.9×+1.8×

Where this comes from

Reported directly by OraSure Technologies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: OraSure Technologies’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001116463-26-000052
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
NET REVENUES:
Products and services$29,724$29,847$56,100$58,844
Other9151,3952,4642,329
30,63931,24258,56461,173
COST OF PRODUCTS AND SERVICES SOLD17,32218,08333,44335,715
Gross profit13,31713,15925,12125,458
OPERATING EXPENSES:
Research and development9,43711,40123,09121,004

Item 1. FINANCIAL STATEMENTS

FAQ

What is OraSure Technologies's risk assessment testing — net revenues?
OraSure Technologies (OSUR) reported risk assessment testing — net revenues of $0 in Q2 2026.
How has OraSure Technologies's risk assessment testing — net revenues changed year-over-year?
OraSure Technologies's risk assessment testing — net revenues decreased by 100.0% year-over-year, from $446K to $0.
What is the long-term trend for OraSure Technologies's risk assessment testing — net revenues?
Over 4 years (2021 to 2025), OraSure Technologies's risk assessment testing — net revenues has grown at a -33.7% compound annual growth rate (CAGR), from $9.68M to $1.87M.
What does risk assessment testing — net revenues mean?
This metric represents the total revenue generated from the sale of diagnostic products and services specifically designed for risk assessment and screening. It reflects the market demand for specialized testing solutions used to identify health risks or infectious disease exposure. Monitoring this revenue stream helps evaluate the commercial performance and growth trajectory of the company's dedicated risk assessment business unit.

Ask your AI about OraSure Technologies's risk assessment testing — net revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude